A PHARMACEUTICAL COMPOSITION CONTAINING EZRIN MUTATED ON TYROSINE 353
摘要
The invention relates to a pharmaceutical composition containing an effective amount of ezrin mutated on tyrosin 353, or a functional fragment or derivative thereof, in association with a pharmaceutically acceptable carrier, for use preferably in the prevention and/or treatment of tumors.
申请公布号
WO9947150(A9)
申请公布日期
1999.11.18
申请号
WO1999EP02054
申请日期
1999.03.18
申请人
INSTITUT CURIE;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.);ARPIN, MONIQUE;CREPALDI, TIZIANA;GAUTREAU, ALEXIS;LOUVARD, DANIEL
发明人
ARPIN, MONIQUE;CREPALDI, TIZIANA;GAUTREAU, ALEXIS;LOUVARD, DANIEL
